BridgeMD
New treatment option for Hepatic Cytolysis
Official title Identification of Anti-HIF 1alpha Autoantibodies in Patients With Anorexia Nervosa and Characterization of Their Pathogenic Potential in Undernutrition-associated Hepatic Cytolysis
ClinicalTrials.gov ID: NCT06869590
What this study is testing
- What it's testing
- Anorexia nervosa (AN) is a psychiatric disorder belonging to the eating disorders (EDs). It is internationally recognized as a priority for improving health care.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Experimental group:
- Male or female, 6 to 65 years of age
- Anorexia nervosa diagnosed according to DSM-5 criteria
- Presence of undernutrition according to HAS 2019 criteria
- Patient having received information about the study and having signed an informed consent form
You likely can't join if
- Patient in a period of exclusion from another research protocol at the time consent is signed.
- Opposition of patient and parents or legal guardians
- Psychiatric disorder preventing patient consent to study
- Person unable to understand the French language
- people covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of...
See the full eligibility criteria
- Experimental group:
- Male or female, 6 to 65 years of age
- Anorexia nervosa diagnosed according to DSM-5 criteria
- Presence of undernutrition according to HAS 2019 criteria
- Patient having received information about the study and having signed an informed consent form
- Beneficiary or beneficiary of a social security scheme Control group:
- Minor patients :
- Male or female strictly under 18 years of age
- Patients undergoing scheduled non-inflammatory surgery (orthopedic, ENT, etc.)
- Patients who have been informed about the study and have signed an informed consent form.
- Patients who are beneficiaries or entitled beneficiaries of a social security scheme.
- Patients without anorexia with livers cytolysis :
- Male or female between 18 and 65 years of age
- With hepatic cytolysis determined by an ALT value at least equal to twice the normal value
- Patient having received information about the study and having signed an informed consent form
- Patient who is a beneficiary or eligible beneficiary of a social security scheme.
- samples Etablissement Français de don de sang: no specific criteria
- Patient in a period of exclusion from another research protocol at the time consent is signed.
- Opposition of patient and parents or legal guardians
- Psychiatric disorder preventing patient consent to study
- Person unable to understand the French language
- people covered by articles L1121-5 to 1121-8 of the French Public Health Code (minors, adults under guardianship or trusteeship, patients deprived of their liberty, pregnant or breast-feeding women).
The study team makes the final eligibility decision.
Where it's taking place
- Marseille, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Marseille, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.